Clinical Trial Update: A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study [Phase 4]

View source ↗

Summary

Phase 4 study update evaluating hepatitis C response rates in real-world patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: American Research Corporation | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED